60

Chimin Health Management Co LtdSHG 603222 Stock Report

Last reporting period 30 Sep, 2023

Updated 16 Oct, 2024

Last price

Market cap $B

0.425

Micro

Exchange

XSHG - Shanghai Stock Exchange

603222.SS Stock Analysis

60

Uncovered

Chimin Health Management Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

19/100

Low score

Market cap $B

0.425

Dividend yield

0.73 %

Shares outstanding

537.24 B

Chimin Health Management Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Taizhou, Zhejiang and currently employs 2,243 full-time employees. The company went IPO on 2015-02-17. The firm primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The firm distributes its products within domestic market and to overseas markets.

View Section: Eyestock Rating